These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 16413662)

  • 1. Are all alpha-blockers created the same?
    Irani J
    Eur Urol; 2006 Mar; 49(3):420-2. PubMed ID: 16413662
    [No Abstract]   [Full Text] [Related]  

  • 2. [Alpha blockers in the treatment of benign hyperplasia of the prostate].
    Gómez Sancha F; Fernández Arjona M; Peinado Ibarra F; Fernández Borrell A; Mínguez Martínez R; Pereira Sanz I
    Rev Clin Esp; 1997 May; 197(5):358-62. PubMed ID: 9280971
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacotherapy for benign prostatic hyperplasia--the potential for alpha 1-adrenoceptor subtype-specific blockade.
    Chapple CR
    Br J Urol; 1998 Mar; 81 Suppl 1():34-47; discussion 64-6. PubMed ID: 9589016
    [No Abstract]   [Full Text] [Related]  

  • 4. Are the new selective alpha-blockers better than non-selective alpha-blockers for benign prostatic hyperplasia?
    Bèïque L; Por CP; Evans MF
    Can Fam Physician; 1998 Dec; 44():2659-62. PubMed ID: 9870119
    [No Abstract]   [Full Text] [Related]  

  • 5. Benign prostatic hyperplasia.
    Doherty AP
    Hosp Med; 2003 Feb; 64(2):114. PubMed ID: 12619342
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of various alpha1-adrenergic receptor antagonists on pupillary dilation.
    Arikan G; Demir O; Yaman A; Bozkurt O; Saatci AO; Durak I; Esen A
    Ann Ophthalmol (Skokie); 2008; 40(1):19-21. PubMed ID: 18556976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A meta-analysis on the efficacy and tolerability of alpha1-adrenoceptor antagonists in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction.
    Djavan B; Marberger M
    Eur Urol; 1999; 36(1):1-13. PubMed ID: 10364649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current role of alpha-blockers in the treatment of benign prostatic hyperplasia.
    Kaplan SA
    BJU Int; 2008 Nov; 102 Suppl 2():3-7. PubMed ID: 19032603
    [No Abstract]   [Full Text] [Related]  

  • 9. [Alfuzosin in benign prostatic hyperplasia. A new principle is evaluated. Report of a study].
    Fortschr Med Suppl; 1995; 166():1-12. PubMed ID: 7537599
    [No Abstract]   [Full Text] [Related]  

  • 10. [5-alpha reductase inhibitors or alpha blockers? The combination brakes best prostatic hyperplasia].
    MMW Fortschr Med; 2002 Oct; 144(44):56. PubMed ID: 12494605
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical results with alpha-blockers in patients with symptomatic benign prostatic hyperplasia.
    Mensink HJ
    Prog Clin Biol Res; 1994; 386():285-9. PubMed ID: 7528396
    [No Abstract]   [Full Text] [Related]  

  • 12. Medical therapy for benign prostatic hyperplasia: a review of the literature.
    Clifford GM; Farmer RD
    Eur Urol; 2000 Jul; 38(1):2-19. PubMed ID: 10859436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the newer alpha, -adrenergic-receptor antagonists in the treatment of benign prostatic hyperplasia-related lower urinary tract symptoms.
    Lowe FC
    Clin Ther; 2004 Nov; 26(11):1701-13. PubMed ID: 15639685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of lower urinary tract symptoms in benign prostatic hypertrophy with α-blockers.
    Belayneh M; Korownyk C
    Can Fam Physician; 2016 Sep; 62(9):e523. PubMed ID: 27629686
    [No Abstract]   [Full Text] [Related]  

  • 15. [Alpha blockers in use for symptomatic benign prostatic hyperplasia--are all drugs born equal?].
    Bar-Yosef Y; Mabjeesh NJ; Laufer M; Neulander EZ; Kaver I; Matzkin H
    Harefuah; 2008 Jun; 147(6):514-9, 574. PubMed ID: 18693628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacologic treatment of benign prostatic hyperplasia].
    Romics I
    Orv Hetil; 2003 Sep; 144(37):1809-14. PubMed ID: 14596018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of alpha1-adrenoceptor selectivity in the management of benign prostatic hyperplasia.
    Pool JL; Kirby RS
    Int Urol Nephrol; 2001; 33(3):407-12. PubMed ID: 12230262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bunazosin. Andante, Detantol, E 1015, E 643, EA 0643.
    Drugs R D; 1999 Dec; 2(6):417-9. PubMed ID: 10763455
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy and safety of tamsulosin in the treatment of benign prostatic hyperplasia.
    Kawabe K
    Br J Urol; 1995 Jul; 76 Suppl 1():63-7. PubMed ID: 7544217
    [No Abstract]   [Full Text] [Related]  

  • 20. Stroke associated with alpha blocker therapy for benign prostatic hypertrophy.
    Mansoor GA; Tendler BE
    J Natl Med Assoc; 2002 Jan; 94(1):1-4. PubMed ID: 11837346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.